Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: MICROBIOTIX, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-07-01 to 2023-06-30
Current total value of award: $1204539
Description: TO DEVELOP PHENOXYACETAMIDE T3SS INHIBITORS AS ADJUNCTIVE AGENTS TO ANTIBACTERIAL THERAPY FOR MDR P. AERUGINOSA INFECTIONS.